Connection

Marc Bonten to Escherichia coli Infections

Back to Details
This is a "connection" page, showing publications Marc Bonten has written about Escherichia coli Infections.
Marc Bonten
Connection Strength
1.122
Escherichia coli Infections
  1. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST). BMC Infect Dis. 2018 Dec 05; 18(1):626.
    View in: PubMed
    Score: 0.570
  2. Attributable sources of community-acquired carriage of Escherichia coli containing ß-lactam antibiotic resistance genes: a population-based modelling study. Lancet Planet Health. 2019 08; 3(8):e357-e369.
    View in: PubMed
    Score: 0.149
  3. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe. J Antimicrob Chemother. 2018 11 01; 73(11):2973-2980.
    View in: PubMed
    Score: 0.142
  4. Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis. J Antimicrob Chemother. 2018 02 01; 73(2):339-347.
    View in: PubMed
    Score: 0.134
  5. Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials. PLoS One. 2017; 12(3):e0174094.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.